CECO Environmental Upsizes Credit Facility to $400 Million

DALLAS, Oct. 15, 2024 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment, and industrial equipment, has announced a significant upsize in the form of an amendment and restatement of its credit facility, increasing it to a $400 million senior secured revolving credit […]

MGA Entertainment and Sanrio(R) Partner to Create the Newest Mini Collectible Collaboration MGA’s Miniverse(TM) Make It Mini Food(TM) Hello Kitty(R)

LOS ANGELES, Oct. 15, 2024 (GLOBE NEWSWIRE) — MGA Entertainment (MGA), one of the largest privately held toy and entertainment companies in the world, announced today the newest collection from its globally popular mini collectible brand, MGA’s Miniverse(TM), in partnership with Sanrio(R), the global lifestyle brand and home to pop icon Hello Kitty(R). The new

“Ted Lasso” Goalie, Moe Jeudy-Lamour, Debuts Hot New Thenar Workout for Strong Thumbs with FREE Fitness Equipment – Clean Cult’s Laundry Detergent Sheets

Score a clean sheet with the latest cult fitness craze: a thumb workout like no other. Claim your free workout equipment at strongthumbs.com Clean Cult, the next-gen brand slashing 90% of single-use plastic from home cleaning rituals, is teaming up with “Ted Lasso” goalie Moe Jeudy-Lamour to launch the freshest fitness craze since shake weights:

Take a Bite Out of Snack Time with 7-Eleven’s Hot Dog Flavored Chips

Enjoy the iconic Big Bite® Hot Dog flavor, now packed into crunchy, wavy potato chips 7-Eleven, Inc., the world’s largest convenience retailer, is introducing a new, delicious addition to its snacking lineup: 7-SelectTM Big Bite® Hot Dog Chips. https://mma.prnewswire.com/media/2530152/7_Select_Big_Bite_Potato_Chips_HR_1280x1280.jpg Inspired by the iconic Big Bite® Hot Dog, customers can get their hands on the mouthwatering

Gan & Lee Pharmaceuticals’ Three Innovative Drugs: GZR18 Injection, GZR4 Injection, and GZR101 Injection Achieve Primary Endpoints in Phase 2 Clinical Studies

— After 24 weeks of treatment in patients with Type 2 diabetes, the bi-weekly GLP-1 receptor agonist GZR18 injection showed superior efficacy in lowering HbA1c and body weight compared to semaglutide (Ozempic®). — After 16 weeks of treatment in patients with Type 2 diabetes, the once-weekly insulin analog GZR4 injection demonstrated superior HbA1c reduction in

Cyngn Announces Raymond West, a Leading Dealer with $800M+ in Annual Sales, Will Begin Selling DriveMod Tuggers

Cyngn Inc. (Nasdaq: CYN) today announced the expansion of its dealer network to include Raymond West. A leading distributor and integrator of intralogistics solutions, Raymond West will begin selling Cyngn’s autonomous DriveMod Tugger. The autonomous tuggerintegrates Cyngn’s AV technology with Motrec’s MT-160. https://mma.prnewswire.com/media/2530239/Raymond_West.jpg “With 21 branches across the West Coast, Raymond West is an impressive

Sinai Health Foundation calls for urgent support to transform menopause care

Women are hot – very hot – and bothered that menopause remains poorly understood and deeply underfunded With more than 50 per cent of a Canadian woman’s lifetime spent inperimenopause, menopause and post menopause and an estimated $3.5 billion in national revenue lost annually due to unmanaged menopause symptoms, Sinai Health Foundation is taking a

Kharmagtai Maiden Ore Reserve, Updated Mineral Resource

TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu, XAM or the Company) is pleased to report an increase in the Mineral Resource Estimate (Resource, Mineral Resource Estimate or MRE) and a Maiden Ore Reserve for its flagship copper-gold project at Kharmagtai, in the South Gobi region of Mongolia

Amwell to report third quarter 2024 operating results

BOSTON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Amwell(R) (NYSE: AMWL), a leader in digital care, will report third quarter 2024 operating results on Wednesday, Oct. 30. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the

Allyx Therapeutics Awarded $3.3 Million NIH Grant to Support Further Clinical Studies of Lead Candidate ALX-001

NEW HAVEN, Conn., Oct. 15, 2024 (GLOBE NEWSWIRE) — Allyx Therapeutics announced today that it has been awarded a $3.3 million grant from the National Institutes of Health as part of its Small Business Innovation Research Commercial Readiness Pilot program. This funding will support further investigation of Allyx’s lead clinical asset, ALX-001, a highly-selective, first-in-class,

Scroll to Top